Details

---

Manufacturer
GLAXOSMITHKLINE BIOLOGICALS S.A(BELGIUM)

Registraction Number
MAL20091945ARZ

Contents:

• Active Ingredients: Pneumococcal polysaccharides from 10 serotypes (1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F).
• Conjugated to: Protein D (derived from non-typeable Haemophilus influenzae), diphtheria toxoid, and tetanus toxoid.
• Adsorbed on: Aluminium phosphate.

Indication:
SYNFLORIX is indicated for active immunization against invasive disease, pneumonia, and acute otitis media caused by Streptococcus pneumoniae in infants and children aged 6 weeks to 5 years.
Instructions:

1. Dosage Schedule:
   • Infants (6 weeks to 6 months): Three doses with an interval of at least one month between doses. A booster dose is recommended at least 6 months after the third dose.
   • Infants (7 to 11 months): Two doses with an interval of at least one month between them. A booster dose is recommended at least 2 months after the second dose.
   • Children (12 months to 5 years): Two doses with an interval of at least 2 months between them.
2. Administration: Inject intramuscularly into the anterolateral thigh or deltoid muscle.
3. Storage: Store in a refrigerator between 2°C and 8°C. Do not freeze.